Related Experiment Video

Updated: Jul 8, 2025

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
07:47

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

11.6K

A Hybrid Antimicrobial Peptide Targeting Staphylococcus aureus with a Dual Function of Inhibiting Quorum Sensing

Haixing Lin1,2, Li Song1, Shaofen Zhou1

  • 1Group of peptides and natural products Research, School of Pharmaceutical Sciences, Southern Medical University, 1838 Guangzhou Avenue North, Guangzhou 510515, P. R. China.

Journal of Medicinal Chemistry
|December 15, 2023
PubMed

Insights

A novel hybrid peptide, CP7-FP13-2, effectively combats Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) infections. This peptide inhibits virulence and biofilm formation while also killing bacteria, offering a promising strategy against antibiotic resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Drug Discovery

Background:

  • Community-associated methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of bacterial infections.
  • Antivirulence therapy offers a novel approach to treating infections without promoting pathogen resistance.
  • Staphylococcus aureus (S. aureus) virulence factors and biofilm formation contribute to persistent infections.

Purpose of the Study:

  • To develop a novel hybrid peptide with both antivirulence and antimicrobial properties against S. aureus.
  • To evaluate the efficacy of the hybrid peptide CP7-FP13-2 in vitro and in a mouse model.

Main Methods:

  • A cyclic peptide CP7 (AIP-III variant) was conjugated with a broad-spectrum antimicrobial peptide (AMP) to create CP7-FP13-2.
  • The hybrid peptide's ability to inhibit S. aureus virulence, biofilm formation, and bacterial cell membrane integrity was assessed.
  • Antimicrobial efficacy was tested in a S. aureus-infected Kunming mice model.

Main Results:

  • CP7-FP13-2 specifically inhibited S. aureus virulence at low micromolar concentrations.
  • The hybrid peptide demonstrated bactericidal activity against S. aureus, including MRSA, by disrupting cell membranes.
  • CP7-FP13-2 effectively inhibited S. aureus biofilm formation and showed efficacy in a mouse infection model.

Conclusions:

  • The hybrid peptide CP7-FP13-2 presents a dual-action strategy against S. aureus virulence and resistance.
  • This approach offers a promising therapeutic avenue for combating challenging S. aureus and MRSA infections.
  • CP7-FP13-2 warrants further investigation as a potential treatment for S. aureus-related diseases.

More Related Videos

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

24.5K
Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

6.3K

Related Concept Videos

Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
32.3K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1000
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K